NCT04643938 is a clinical trial in Recurrent Early Pregnancy Loss, sponsored by Peking University Third Hospital.

Who is sponsoring NCT04643938?

NCT04643938 is sponsored by Peking University Third Hospital.

What condition does NCT04643938 study?

NCT04643938 studies Recurrent Early Pregnancy Loss.

Is NCT04643938 still recruiting?

NCT04643938 is currently completed. Last updated 25 November 2020.

Last reviewed 2020-11-25 · How we verify

NCT04643938

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PGT-A in Screening of Embryos in the Treatment of Unexplained Recurrent Miscarriage

Completed Last updated 25 November 2020

What this trial tests

trial in Recurrent Early Pregnancy Loss in 69 participants. Completed in 1 February 2020.

Timeline

1 January 2020

Primary endpoint
1 January 2020

1 February 2020

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	69
Start date	1 January 2020
Primary completion	1 January 2020
Estimated completion	1 February 2020
Sites	1 location across China

Conditions studied

Recurrent Early Pregnancy Loss — all drugs for Recurrent Early Pregnancy Loss →

Sponsor

Peking University Third Hospital

Who can join

Adults 20 to 46, female only, with Recurrent Early Pregnancy Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

uRM patients selected PGT-A from 2012 to 2016 were included in this study. Their clinical outcomes were prospectively observed and analyzed to explore the factor influenced the outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04643938 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 25 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04643938.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing